leuprolide acetate ( lupron , tap pharmaceuticals , north chicago ) , a gonadotropin-releasing hormone analogue , was administered subcutaneously at a 1-mg dose for a minimum of 8 weeks to 23 patients with refractory epithelial ovarian cancer .
C0700596
leuprolide acetate
C0701459
lupron